This site is intended for healthcare professionals only
The Competition Appeal Tribunal (CAT) has dismissed Lexon (UK)’s appeal of a CMA fine and investigation, which said the company broke the law over the supply of nortriptyline.
Through an investigation carried out last year, the Competition and Markets Authority (CMA) concluded that King Pharmaceuticals, Auden Mckenzie, Lexon (UK) and Alissa Healthcare broke the law in relation to the supply of nortriptyline, a drug that is used to relieve the symptoms of depression.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.
C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…
Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.
Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.
Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.
